PI vs. ABCL

Last updated Apr 1, 2026

Compare and contrast key facts about Impinj, Inc. (PI) and AbCellera Biologics Inc. (ABCL).

Performance

PI vs. ABCL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Impinj, Inc. (PI) and AbCellera Biologics Inc. (ABCL). The values are adjusted to include any dividend payments, if applicable.

PI vs. ABCL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
PI Impinj, Inc.	-40.98%	19.79%	61.35%	-17.54%	23.09%	111.85%	3.13%
ABCL AbCellera Biologics Inc.	2.05%	16.72%	-48.69%	-43.63%	-29.16%	-64.46%	-31.68%

Fundamentals

Market Cap PI : $3.10B ABCL : $1.04B
EPS PI : -$0.37 ABCL : -$0.49
PS Ratio PI : 8.45 ABCL : 13.88
PB Ratio PI : 14.80 ABCL : 1.08
Total Revenue (TTM) PI : $361.08M ABCL : $75.13M
Gross Profit (TTM) PI : $189.68M ABCL : -$36.22M
EBITDA (TTM) PI : -$2.09M ABCL : -$126.64M

Returns By Period

In the year-to-date period, PI achieves a -40.98% return, which is significantly lower than ABCL's 2.05% return.

PI

• 1D: 6.90%
• 1M: -16.27%
• YTD: -40.98%
• 6M: -43.18%
• 1Y: 13.23%
• 3Y*: -8.83%
• 5Y*: 11.74%
• 10Y*: —

ABCL

• 1D: 6.40%
• 1M: -3.32%
• YTD: 2.05%
• 6M: -30.62%
• 1Y: 56.50%
• 3Y*: -22.65%
• 5Y*: -35.27%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

PI vs. ABCL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PI

PI Risk / Return Rank: 49
PI Sharpe Ratio Rank: 48
PI Sortino Ratio Rank: 52
PI Omega Ratio Rank: 52
PI Calmar Ratio Rank: 47
PI Martin Ratio Rank: 47

ABCL

ABCL Risk / Return Rank: 65
ABCL Sharpe Ratio Rank: 67
ABCL Sortino Ratio Rank: 70
ABCL Omega Ratio Rank: 65
ABCL Calmar Ratio Rank: 62
ABCL Martin Ratio Rank: 59

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PI vs. ABCL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Impinj, Inc. (PI) and AbCellera Biologics Inc. (ABCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PI	ABCL	Difference
Sharpe ratio Return per unit of total volatility	0.16	0.73	-0.56
Sortino ratio Return per unit of downside risk	0.84	1.61	-0.76
Omega ratio Gain probability vs. loss probability	1.11	1.18	-0.07
Calmar ratio Return relative to maximum drawdown	0.19	0.93	-0.74
Martin ratio Return relative to average drawdown	0.43	1.83	-1.41
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PI vs. ABCL - Sharpe Ratio Comparison

The current PI Sharpe Ratio is 0.16, which is lower than the ABCL Sharpe Ratio of 0.73. The chart below compares the historical Sharpe Ratios of PI and ABCL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	PI	ABCL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.16	0.73	-0.56
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.17	-0.53	+0.70
Sharpe Ratio (All Time) Calculated using the full available price history	0.27	-0.60	+0.87

Correlation

The correlation between PI and ABCL is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

PI vs. ABCL - Dividend Comparison

Neither PI nor ABCL has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

PI vs. ABCL - Drawdown Comparison

The maximum PI drawdown since its inception was -81.35%, smaller than the maximum ABCL drawdown of -96.72%. Use the drawdown chart below to compare losses from any high point for PI and ABCL.

Drawdown Indicators

	PI	ABCL	Difference
Max Drawdown Largest peak-to-trough decline	-81.35%	-96.72%	+15.37%
Max Drawdown (1Y) Largest decline over 1 year	-62.24%	-54.94%	-7.30%
Max Drawdown (5Y) Largest decline over 5 years	-73.79%	-94.35%	+20.56%
Current Drawdown Current decline from peak	-57.55%	-94.07%	+36.52%
Average Drawdown Average peak-to-trough decline	-36.51%	-83.30%	+46.79%
Ulcer Index Depth and duration of drawdowns from previous peaks	27.87%	27.87%	0.00%

Volatility

PI vs. ABCL - Volatility Comparison

Impinj, Inc. (PI) has a higher volatility of 23.02% compared to AbCellera Biologics Inc. (ABCL) at 12.03%. This indicates that PI's price experiences larger fluctuations and is considered to be riskier than ABCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PI	ABCL	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.02%	12.03%	+10.99%
Volatility (6M) Calculated over the trailing 6-month period	59.56%	53.26%	+6.30%
Volatility (1Y) Calculated over the trailing 1-year period	81.67%	78.17%	+3.50%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	69.48%	66.57%	+2.91%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	72.95%	69.65%	+3.30%

Financials